Grantham, Mayo, Van Otterloo & Co (GMO)’s Axalta AXTA Stock Holding History
Bought
Maintained
Sold
Other funds holding AXTA
Grantham, Mayo, Van Otterloo & Co (GMO)'s AXTA Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Axalta (AXTA) in Q2 2026: 323,578 shares worth $11.1M. The stake represents 0.02% of the portfolio and ranks #246 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in AXTA as recently as Q1 2020.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AXTA in Q4 2019 and has held it in 3 quarters since. The position peaked at $26.5M in Q1 2020. 362 funds tracked by Wall St. Rank hold AXTA as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 323,578 shares of Axalta worth $11.1M as of Q2 2026.
- Axalta was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
- Axalta made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #246 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axalta in Q4 2019 and has held it in 3 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Axalta position peaked at $26.5M in Q1 2020.
- 362 funds tracked by Wall St. Rank held Axalta as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.